Skip to main content
. 2020 Sep 28;18(9):e3000870. doi: 10.1371/journal.pbio.3000870

Table 1. LC-MS/MS instrument conditions for targeted lipidomic analysis.

Lipid Class/Subclass Parent Ion Fragmentation No. of Lipid Species ISTD ISTD (pmol)/Sample Collision Energy (V)
Sphingosine [M + H]+ NL, 18.0 Da 4 Sph(d17:1) 20 8
Sphingosine-1-phosphate [M + H]+ sphingoid-base specific 4 Sph(d17:1) 25 10
Dihydroceramide [M + H]+ sphingoid-base specific 6 dhCer(d18:0/8:0) 50 31
Ceramide [M + H]+ sphingoid-base specific 50 Cer(d18:1-d7/17:0) 50 25
Deoxyceramide [M + H]+ sphingoid-base specific 11 Cer(d18:1/17:0) 50 25
Monohexosylceramide [M + H]+ sphingoid-base specific 14 HexCer (d18:1/16:0) d3 50 33
Dihexosylceramide [M + H]+ sphingoid-base specific 10 Hex2Cer(d18:1/16:0) d3 50 53
Trihexosylcermide [M + H]+ PI, m/z 264.3 6 Hex3Cer(d18:1/17:0) 25 57
GM3 ganglioside [M + H]+ sphingoid base 8 Hex3Cer(d18:1/17:0) 25 57
GM1 ganglioside [M + 2H]2+ PI, m/z 366.2 1 Hex3Cer(d18:1/17:0) 25 9
Sulfatide [M + H]+ PI, m/z 264.3 10 sulfatide(d18:1/12:0) 10 56
Ceramide-1-phosphate [M + H]+ PI, m/z 264.3 1 Cer(d18:1/17:0) 50 29
Sphingomyelin [M + H]+ PI, m/z 184.1 44 SM(d18:1/12:0) 100 25
Phosphatidylcholine [M + H]+ PI, m/z 184.1 70 PC(13:0/13:0) 100 21
Alkylphosphatidylcholine [M + H]+ PI, m/z 184.1 22 PC(13:0/13:0) 100 21
Alkenylphosphatidylcholine [M + H]+ PI, m/z 184.1 26 PC(13:0/13:0) 100 21
Lysophosphatidylcholine [M + H]+ PI, m/z 184.1 and m/z 104.1 61 LPC(13:0) 100 21
Lysoalkylphosphatidylcholine [M + H]+ PI, m/z 104.1 10 LPC(13:0) 100 21
Lysoalkenylphosphatidylcholine [M + H]+ PI, m/z 104.1 6 LPC(13:0) 100 21
Phosphatidylethanolamine [M + H]+ NL, 141.0 Da 37 PE(17:0/17:0) 100 17
Alkylphosphatidylethanolamine [M + H]+ NL, 141.0 Da 14 PE(17:0/17:0) 100 17
Alkenylphosphatidylethanolamine [M + H]+ acyl-chain specific 54 PE(17:0/17:0) 100 17
Lysophosphatidylethanolamine [M + H]+ NL, 141.0 Da 14 PE(17:0/17:0) 100 17
Lysoalkenylphosphatidylethanolamine [M + H]+ NL, 171.9 Da 4 PE(17:0/17:0) 100 19
Phosphatidylinositol [M + NH4]+ NL, 277.0 Da 27 PE(17:0/17:0) 100 17
Lysophosphatidylinositol [M + NH4]+ NL, 277.0 Da 8 LPI(13:0) 20 17
Phosphatidylserine [M + H]+ NL, 185.0 Da 7 PS(17:0/17:0) 50 25
Phosphatidylglycerol [M + NH4]+ NL, 189.0 Da 4 PG(17:0/17:0) 50 21
Free cholesterol [M + NH4]+ PI, m/z 369.3 1 COH d7 10,000 23
Dehydrocholesterol [M + NH4]+ PI, m/z 369.4 4 CE(18:0) d6 1,000 23
Cholesteryl ester [M + NH4]+ PI, m/z 369.3 28 CE(18:0) d6 1,000 10
Acylcarnitines [M + H]+ PI, m/z 85.1 14 Acylcarnitine(16:0) d3 10 30
Diacylglycerol [M + NH4]+ NL, fatty acid 25 DG(15:0/15:0) 200 21
Triacylglycerol [M + NH4]+ NL, fatty acid 112 TG(17:0/17:0/17:0) 100 21
Alkyl-diacylglycerol [M + NH4]+ NL, fatty acid 28 TG(17:0/17:0/17:0) 100 21
Ubiquinone [M + NH4]+ PI, m/z 197.0 1 Hex3Cer(d18:1/17:0) 50 21

Abbreviations: CE, cholesteryl ester; Cer, ceramide; Cer-1-P, ceramide-1-phosphate; COH, free cholesterol; DE, dehydrocholesterol; deoxyCer, deoxyceramide; DG, diacylglycerol; dhCer, dihydroceramide; GM3/1, GM3/GM1 ganglioside; HexCer, monohexosylceramide; Hex2Cer, dihexosylceramide; Hex3Cer, trihexosylceramide; ISTD, internal standard; LC-M/MS, liquid chromatography tandem mass-spectrometry; LPC, lysophosphatidylcholine; LPC(O), lysoalkylphosphatidylcholine; LPC(P), lysoalkenylphosphatidylcholine; LPE, lysophosphatidylethanolamine; LPE(P), lysoalkenylphosphatidylethanolamine; LPI, lysophosphatidylinositol; NL, neutral loss; PC, phosphatidylcholine; PC(O), alkylphosphatidylcholine; PC(P), alkenylphosphatidylcholine; PE, phosphatidylethanolamine; PE(O), alkylphosphatidylethanolamine; PE(P), alkenylphosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin; Sph, sphingosine; S-1-P, sphingosine-1-phosphate; TG, triacylglycerol; TG(O), alkyl-diacylglycerol.